Search

everythinglearnresearchcommunity

for

Search:↓

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Finasteride and minoxidil together work best for male hair loss.

The document concludes that hair loss in women is treated with medications, therapies, and surgery in Western medicine, and with acupuncture and herbs in Chinese medicine, but hereditary hair loss is hard to reverse.

MorrF improves hair growth better than minoxidil alone.

Use minoxidil for hair loss treatment; assess results after 6 months.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

New treatments for skin and hair repair show promise, but further improvements are needed.

Secretome-based therapies could improve hair growth better than current treatments.

TH07 treatment is promising for hair growth, with higher satisfaction in males.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Tamsulosin increases the risk of floppy iris during eye surgery.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Some nonsurgical hair loss treatments are effective, especially if started early.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.